Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07517107) titled 'Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric Cancer' on April 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fudan University

Condition: Gastric Cancer

Intervention: Diagnostic Test: Circulating Tumor DNA (ctDNA) Analysis

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: January 1, 2026

Target Sample Size: 600

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07517107

Published ...